Asia-Pacific $1.33 Billion Continuous Glucose Monitoring System Market Forecast 2017-2025 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Asia-Pacific Continuous Glucose Monitoring System Market Forecast 2017-2025" report to their offering.

The APAC CGMS market was valued at $40 million in the year 2016 and is expected to reach a value of $1339.25 million by 2025 with a CAGR of 48.7%.

The Asia-Pacific CGMS market is anticipated to report the highest growth during the forecast period. An increase in awareness, high budget, and rise in the number of chronic diseases and the accelerating investment in healthcare infrastructure by the government are expected to be the market drivers for the growth of continuous glucose monitoring system market. The high acceleration in obesity cases and awareness and knowledge of disease management will lead to market growth on a global level.

The global CGMS market is anticipated to expand during the forecast years 2017-2025. The diverse factors leading to the CGMS market are an augmented increase in the number of people suffering from diabetes, authorization of artificial pancreas, greater awareness, and improved healthcare infrastructure and ease of using CGMS devices.

The market is segmented by application, product type, and geography. There are diverse product types comprising CGMS including the transmitters and receivers, and the sensors. The Sensors are further segmented on the basis of holter type retrospective sensors, insulin pumps, non-invasive glucose sensors, minimally invasive glucose sensors and real-time sensors. The glucose monitors applications end-users include homes, hospitals, diagnostics and clinics.

Key Topics Covered:

1. Research Scope

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market By Component Type

6. Market By Application

7 Key Analytical

8. Regional Analysis

9. Competitive Landscape

- Medtronic

- Dexcom

- ABbott

- Johnson And Johnson

- Insulet Corp

- Tandem Diabetes

- Echo Therapeutics

- Roche Diagnostics

- Nemaura Medical Inc.

- Senseonics

- Glysens Incorporated

For more information about this report visit http://www.researchandmarkets.com/research/cjjc9q/asiapacific

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Glucose Testing, Diabetes Devices , Wearable Technology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Glucose Testing, Diabetes Devices , Wearable Technology